NWO Domain Applied and Engineering Sciences (AES) has granted project ULTRA-X-TREME 4 million euros for developing new 3D ultrasound techniques allowing patient-specific diagnosis of vascular problems and prevention of unnecessary operations. The project is led by Chris de Korte, professor of Medical Ultrasound Techniques at Radboudumc and professor of Medical Ultrasound Imaging at the University of Twente.
New techniques
As part of the program Ultrafast Ultrasound Imaging for Extended Diagnosis and Treatment of Vascular Disease (ULTRA-X-TREME), an international research team is to develop new and more accurate three-dimensional vascular wall and perfusion ultrasound imaging techniques. The team has been granted four million euros by the funding instrument Perspectief of NWO Domain AES. In the next five years, under the supervision of Chris de Korte, professor of Medical Ultrasound Techniques at Radboud university medical center and professor of Medical Ultrasound Imaging at the University of Twente, the researchers will develop new ultrasound sensors, contrast agents and analysis techniques to more accurately assess the necessity of vascular treatment.
Consortium
The ULTRA-X-TREME consortium is a collaboration of hospitals, international industrial partners and Dutch research groups with a focus on ultrasound techniques and vascular biomechanics. In alphabetical order, the participants in the program are: ANSYS, Bracco Suisse S.A., Catharina Hospital, Erasmus MC, Harteraad, Mindray, Dutch Society for Vascular Surgery (NVvV), Philips Electronics Netherlands, Pie Medical Imaging, Radboud university medical center, Rijnstate Hospital, Delft University of Technology, Eindhoven University of Technology, TomTec Imaging Systems, University of Twente, Vermon S.A. and Verasonics.
Chris de Korte is member of theme Vascular damage.
Related news items
Cum laude PhD defense Marlène Hekman
18 December 2018Based on her excellent thesis and performance during the defense, the doctorate was awarded with the distinction 'cum laude'.
read more
Research into drugs for treating rare diseases can be more efficient and patient-oriented
18 December 2018To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).
read more
Christine Mohrmann stipendium for Karlien Mul
14 December 2018The goal of the stipendium is to enable junior female scientists to perform research abroad and to encourage them to pursue a scientific career in academia.
read more
Call for nominations RIHS Awards 2017 & 2018
14 December 2018RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award and the Supervisor of the year Award. Deadline for nominations is 14 January 2019.
read more
Bart Kiemeney among most cited researchers
13 December 2018Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.
read more
Metal surgical implants can activate drugs
13 December 2018Marja Bulte-ter Meer and Leo Schultze Kool discovered that the iron in metal surgical implants can activate drugs such as antibiotics, thus enabling targeted therapy.
read more